Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Following market measures applied to the underlying equity, Samsung Biologics has announced that trading of its stock futures and stock options will be suspended starting October 30, 2025.
📊 [Key Disclosure Details & Financial Figures]
- Disclosure Title: Trading Suspension and Resumption of Stock Futures and Options
- Target Instruments: Samsung Biologics Stock Futures & Stock Options
- Trading Suspension Date: October 30, 2025
- Trading Resumption Date: Unstated (-)
- Reason for Suspension/Resumption: Trading suspension and lifting of suspension of the underlying asset
- Governing Rules: Article 74 of the Enforcement Rules of the Derivatives Market Business Regulations
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verifying Trading Suspension Enforcement and Future Resumption Schedule for Stock Futures and Options
This disclosure provides notice regarding the trading suspension schedule for Samsung Biologics’ stock futures and options, enacted in conjunction with trading suspension measures placed on the underlying common stock.
It is essential to check the suspension effective date (October 30, 2025) and monitor subsequent announcements regarding the trading resumption date, which will depend on market measures for the underlying equity.
Relevant developments can be verified in Korea Exchange (KRX) derivatives market notices and official market disclosures.
📢 Disclaimer & Source Notice
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Warning: This content is provided solely for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
